Please ensure Javascript is enabled for purposes of website accessibility

Here's Why Mazor Robotics Is Soaring Today

By Brian Feroldi - Updated Sep 21, 2018 at 10:58AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares jump after the company accepts a buyout offer. Here's what investors need to know.

What happened

Shares of Mazor Robotics (MZOR), a robotic surgery company focused on procedures of the spine and brain, jumped 10% as of 10:41 a.m. EDT on Friday. The double-digit move is a response to the news that Medtronic (MDT 0.63%) is acquiring the company.

So what

Here are the details of the proposed transaction:

  • Medtronic is acquiring Mazor for $58.50 per share, or about $1.64 billion.
  • Since Medtronic already owns a substantial amount of Mazor's stock, the net purchase price will be $1.34 billion. 
  • The deal will be made in cash.
  • The boards of both companies have already unanimously approved the transaction.
  • The deal is expected to close in Medtronic's fiscal third quarter, which ends on January 25, 2019.
  • The deal is expected to be "modestly dilutive" to Medtronic's adjusted earnings in fiscal 2019.
Mural of a big fish swallowing a small fish.

Image source: Getty Images.

Geoff Martha, an executive at Medtronic, praised the deal:

The acquisition of Mazor adds robotic-assisted guidance systems to our expanding portfolio of enabling technologies, and we intend to further cultivate Mazor's legacy of innovation in surgical robotics with the site and team in Israel as a base for future growth.

Mazor's CEO Ori Hadomi was also enthusiastic about the combined companies' potential:

The Mazor team and product portfolio's full integration into Medtronic will maximize our impact globally through Medtronic's channels, advance our systems' leadership position in the marketplace, and drive the realization of our vision to heal through innovation.

Now what

Medtronic controls a substantial amount of Mazor's stock and certainly has the financial firepower to complete this deal. Since both companies boards have already given this transaction the unanimous thumbs-up, it looks like a done deal.

Personally, this shareholder thinks that the acquisition makes a lot of sense, but I'm disappointed that I will no longer be able to participate in Mazor's upside over the long term. Given that this looks like a fait accompli, my plan is to sell my shares as soon as the Fool's trading guidelines allow and roll the proceeds into another highly promising healthcare business.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Medtronic plc Stock Quote
Medtronic plc
$103.32 (0.63%) $0.65
Mazor Robotics Ltd. Stock Quote
Mazor Robotics Ltd.

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/16/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.